TRAAP2 - TRAnexamic Acid for Preventing postpartum hemorrhage after cesarean delivery: a multicenter randomized, doubleblind, placebo- controlled trial – a study protocol

BACKGROUND: An antifibrinolytic agent that blocks lysine-binding sites on plasminogen molecules, tranexamic acid reduces bleeding-related mortality in women with postpartum hemorrhage (PPH), especially administered fairly soon after delivery. According to the randomized controlled trials thus far re...

Descripción completa

Detalles Bibliográficos
Autores principales: Sentilhes, Loïc, Daniel, Valérie, Deneux-Tharaux, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995226/
https://www.ncbi.nlm.nih.gov/pubmed/32005192
http://dx.doi.org/10.1186/s12884-019-2718-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995226/
https://www.ncbi.nlm.nih.gov/pubmed/32005192
http://dx.doi.org/10.1186/s12884-019-2718-4

Ejemplares similares